ORALLY ADMINISTERED ADSORBENT, THERAPEUTIC AGENT FOR RENAL DISEASE, AND THERAPEUTIC AGENT FOR LIVER DISEASE

摘要

The purpose of the present invention is to provide spherical active carbon exhibiting excellent adsorption capacity with respect to uremic substances in the body, and particularly with respect to &bgr;-aminoisobutyric acid. Accordingly, provided is an orally administered adsorbent characterized by including spherical active carbon which includes at least 0.5 wt% of nitrogen, which has a specific surface area obtained using the Brunauer-Emmett-Teller (BET) method of 700-3000 m2/g, and which has an average particle size of 0.01-1 mm.